Back
Madrigal Pharmaceuticals Stock Price Chart
Sponsored
MDGL
Sponsored
Free Access to "King of the Quants" Stock Rating System
[Claim Your 3 Free Grades Now]
Sell
43
MDGL
Madrigal Pharmaceuticals
Last Price:
$293.24
Seasonality Move:
-5.31%
7 Day Trial
ALL ACCESS PASS
$
7
Access "King of the Quants" Stock Rating System FREE!
[Claim Your 3 Free Grades Now]-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MDGL is experiencing slight buying pressure.
Madrigal Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 301.78 | Sell |
20-day SMA: | 306.7 | Sell |
50-day SMA: | 316.16 | Sell |
200-day SMA: | 261.38 | Buy |
8-day EMA: | 294.97 | Sell |
20-day EMA: | 303.98 | Sell |
50-day EMA: | 300.22 | Sell |
200-day EMA: | 266.63 | Buy |
Madrigal Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -5.35 | Sell |
Relative Strength Index (14 RSI): | 45.07 | Sell |
Chaikin Money Flow: | 427387 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (290.52 - 322.64) | Sell |
Bollinger Bands (100): | (224.56 - 321.56) | Buy |
Madrigal Pharmaceuticals Technical Analysis
Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
03 | 06 | 07 | 08 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Madrigal Pharmaceuticals Stock
Is Madrigal Pharmaceuticals Stock a Buy?
-
Madrigal Pharmaceuticals share price is 293.64 while MDGL 8-day simple moving average is 301.78, which is a Sell signal.
-
The stock price of MDGL is 293.64 while Madrigal Pharmaceuticals 20-day SMA is 306.70, which makes it a Sell.
-
Madrigal Pharmaceuticals 50-day simple moving average is 316.16 while MDGL share price is 293.64, making it a Sell technically.
-
MDGL stock price is 293.64 and Madrigal Pharmaceuticals 200-day simple moving average is 261.38, creating a Buy signal.
MDGL Technical Analysis vs Fundamental Analysis
Sell
43
Madrigal Pharmaceuticals (MDGL)
is a Sell
Is Madrigal Pharmaceuticals a Buy or a Sell?
-
Madrigal Pharmaceuticals stock is rated a SellThe current Madrigal Pharmaceuticals [MDGL] share price is $293.64. The Score for MDGL is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
Madrigal Pharmaceuticals Stock Info
Market Cap:
6.4B
Price in USD:
293.64
Share Volume:
862.3K
Madrigal Pharmaceuticals 52-Week Range
52-Week High:
368.29
52-Week Low:
168.25
Sell
43
Madrigal Pharmaceuticals (MDGL)
is a Sell
Madrigal Pharmaceuticals Share Price Forecast
-
What is the Madrigal Pharmaceuticals stock price today?The Madrigal Pharmaceuticals stock price is 293.64 USD today.
-
Will MDGL stock go up or go down?Madrigal Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Madrigal Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Madrigal Pharmaceuticals is overvalued.
Is Madrigal Pharmaceuticals Stock a Buy?
-
Madrigal Pharmaceuticals share price is 293.64 while MDGL 8-day exponential moving average is 294.97, which is a Sell signal.
-
The stock price of MDGL is 293.64 while Madrigal Pharmaceuticals 20-day EMA is 303.98, which makes it a Sell.
-
Madrigal Pharmaceuticals 50-day exponential moving average is 300.22 while MDGL share price is 293.64, making it a Sell technically.
-
MDGL stock price is 293.64 and Madrigal Pharmaceuticals 200-day simple moving average is 266.63, creating a Buy signal.
Fundamental Analysis of Madrigal Pharmaceuticals
Is Madrigal Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $4.17 per share, a decrease next quarter of $0.00 per share, an increase this year of $10.60 per share, and an increase next year of $15.74 per share.
Technical Analysis of Madrigal Pharmaceuticals
Should I short Madrigal Pharmaceuticals stock?
-
MDGL Moving Average Covergence Divergence (MACD) indicator is -5.35, suggesting Madrigal Pharmaceuticals is a Sell
-
Madrigal Pharmaceuticals Relative Strength Index (RSI) is 45.07, which suggest Madrigal Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Madrigal Pharmaceuticals is (290.52 - 322.64), which suggest Madrigal Pharmaceuticals is a Buy
-
The Bollinger Bands (100) for Madrigal Pharmaceuticals is (224.56 - 321.56), which suggest Madrigal Pharmaceuticals is a Buy
* Madrigal Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.